There was a significantly higher IL-6 level in de novo AML patients with vitamin D deficiency (< 20 ng/ml) than those with normal vitamin D level on the 1st day of the induction chemotherapy with median values 7.59 pg/ml vs. 2.53 pg/ml and p-value of 0.001(Table 4). Here, IL6 is linked to vitamin D deficiency.